IL38441A0 - Enzyme inhibitors of microbial origin,their production and their use - Google Patents

Enzyme inhibitors of microbial origin,their production and their use

Info

Publication number
IL38441A0
IL38441A0 IL7138441A IL3844171A IL38441A0 IL 38441 A0 IL38441 A0 IL 38441A0 IL 7138441 A IL7138441 A IL 7138441A IL 3844171 A IL3844171 A IL 3844171A IL 38441 A0 IL38441 A0 IL 38441A0
Authority
IL
Israel
Prior art keywords
production
enzyme inhibitors
microbial origin
microbial
origin
Prior art date
Application number
IL7138441A
Other versions
IL38441A (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL38441A0 publication Critical patent/IL38441A0/en
Publication of IL38441A publication Critical patent/IL38441A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • Y10S435/896Streptomyces fradiae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/907Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
IL7138441A 1970-12-28 1971-12-24 Glycoside-hydrolase inhibitors of microbial origin,their production and their use IL38441A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (en) 1970-12-28 1970-12-28 Actinomycete glycoside hydrolase inhibitors

Publications (2)

Publication Number Publication Date
IL38441A0 true IL38441A0 (en) 1972-02-29
IL38441A IL38441A (en) 1974-10-22

Family

ID=5792372

Family Applications (1)

Application Number Title Priority Date Filing Date
IL7138441A IL38441A (en) 1970-12-28 1971-12-24 Glycoside-hydrolase inhibitors of microbial origin,their production and their use

Country Status (28)

Country Link
US (1) US3876766A (en)
JP (3) JPS5734996B1 (en)
KR (1) KR780000248B1 (en)
AR (1) AR193370A1 (en)
AT (1) AT330122B (en)
AU (1) AU461521B2 (en)
BE (1) BE777387A (en)
BG (3) BG25654A3 (en)
CA (1) CA979833A (en)
CH (1) CH594051A5 (en)
CS (1) CS167961B2 (en)
DD (1) DD99395A5 (en)
DE (1) DE2064092C2 (en)
DK (1) DK139533C (en)
ES (1) ES398358A1 (en)
FI (1) FI49774C (en)
FR (1) FR2120073B1 (en)
GB (1) GB1374751A (en)
IE (1) IE35920B1 (en)
IL (1) IL38441A (en)
LU (1) LU64319A1 (en)
NL (1) NL175199C (en)
NO (1) NO135873C (en)
PL (1) PL82900B1 (en)
RO (3) RO61400A (en)
SE (1) SE398357B (en)
SU (1) SU454750A3 (en)
ZA (1) ZA718677B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209834C3 (en) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Manufacture of saccharase inhibitors
DE2209832C3 (en) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Manufacture of saccharase inhibitors
DE2209833C3 (en) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Manufacture of an amylase inhibitor
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (en) * 1976-01-22 1977-08-19 Rhone Poulenc Ind NEW GLYCO-HYDROLASE INHIBITOR AND ITS PREPARATION BY CULTURE OF A STREPTOMYCES
DE2658563A1 (en) * 1976-12-23 1978-06-29 Bayer Ag Glucoside hydrolase inhibitors prodn. from bacteria - esp. Bacillus species useful, e.g., for increasing meat yields and feed efficiency
DE2701890C2 (en) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Streptomycete peptic glycoside hydrolase inhibitor and its use
DE2719912C3 (en) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Process for the isolation of 0- | 4,6-dideoxy-4- [JJl SO, 4,6 / 5) -4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a - D-glucopyranosyl} - (I right arrow 4) -0- a D-glucopyranosyl- (l right arrow 4) -D-glucopyranose from culture broths
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (en) * 1986-01-07 1987-07-16 シャープ株式会社 Electronic automatic flicker
ES2056801T3 (en) * 1986-08-13 1994-10-16 Hoechst Ag OXYRANO-Pseudo-OLIGOSACCHARIDES, PROCEDURE FOR ITS PREPARATION, ITS USE AND PHARMACEUTICAL PREPARATIONS.
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (en) * 1995-03-02 1996-10-31 Bayer Ag Acarbose biosynthesis genes from Actinoplanes sp., Process for their isolation and their use
EP0796915A3 (en) * 1996-03-22 1999-04-14 Bayer Ag Process for the preparation and use of acarviosyl-transferase in the conversion of ascarbose-homologous in acarbose and in the preparation of acarbose-homologous
DE19637591A1 (en) * 1996-09-13 1998-03-19 Bayer Ag Osmocontrolled fermentation process for the production of acarbose
WO2001030796A1 (en) 1999-10-28 2001-05-03 Chong Kun Dang Pharmaceutical Corp. A process for preparing acarbose with high purity
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
IN2014CN04155A (en) 2011-12-08 2015-07-17 Bayer Ip Gmbh
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
JP2022553183A (en) 2019-10-16 2022-12-22 バイエル・アクチエンゲゼルシヤフト Improved method of forming acarbose
MX2022011717A (en) 2020-03-23 2022-12-07 Bay State Milling Company Rapid high amylose wheat seed purity test.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
BG26003A4 (en) 1979-01-12
JPS5734996B1 (en) 1982-07-26
NL175199C (en) 1984-10-01
DD99395A5 (en) 1973-08-05
SU454750A3 (en) 1974-12-25
DE2064092C2 (en) 1983-06-01
JPS57150396A (en) 1982-09-17
US3876766A (en) 1975-04-08
RO63065A (en) 1979-02-15
ES398358A1 (en) 1974-09-01
SE398357B (en) 1977-12-19
ATA1111571A (en) 1975-09-15
CS167961B2 (en) 1976-05-28
JPS57150395A (en) 1982-09-17
LU64319A1 (en) 1972-06-13
DE2064092A1 (en) 1972-07-20
JPS6216638B2 (en) 1987-04-14
IE35920B1 (en) 1976-06-23
FI49774B (en) 1975-06-30
JPS6234396B2 (en) 1987-07-27
NO135873C (en) 1977-06-15
FR2120073B1 (en) 1975-12-26
CH594051A5 (en) 1977-12-30
CA979833A (en) 1975-12-16
GB1374751A (en) 1974-11-20
FI49774C (en) 1975-10-10
AU3721471A (en) 1973-09-27
RO61400A (en) 1977-01-15
NL175199B (en) 1984-05-01
AT330122B (en) 1976-06-10
BG26002A4 (en) 1979-01-12
DK139533B (en) 1979-03-05
BG25654A3 (en) 1978-11-10
FR2120073A1 (en) 1972-08-11
ZA718677B (en) 1972-09-27
KR780000248B1 (en) 1978-07-06
DK139533C (en) 1979-08-20
AR193370A1 (en) 1973-04-23
IE35920L (en) 1972-06-28
AU461521B2 (en) 1975-05-29
BE777387A (en) 1972-06-28
RO63064A (en) 1978-06-15
IL38441A (en) 1974-10-22
NO135873B (en) 1977-03-07
NL7117893A (en) 1972-06-30
PL82900B1 (en) 1975-10-31

Similar Documents

Publication Publication Date Title
IL38441A0 (en) Enzyme inhibitors of microbial origin,their production and their use
CA1000629A (en) Microbiological production of protein
GB1373487A (en) Enzymes their preparation and uses
CA994340A (en) N-substituted imidazoles, their production and use
IL35986A0 (en) Amylase inhibitor,its production and use
AU462715B2 (en) Sulphonyk-2-(arylhydrazino)-2-imidazolines processes for their manufacture and their use as ectroparasiticides
CA922321A (en) Enzyme inhibitors
CA946837A (en) Enzyme inhibitor
JPS55143947A (en) Manufacture of enzyme inhibitor
CA852745A (en) .alpha. AND .gamma.-PICOLINE PRODUCTION
CA839235A (en) Purification of enzyme inhibitors
CA835944A (en) Cultivation and recovery of micro-organisms
JPS55147248A (en) Manufacture of enzyme inhibitor
CA1002518A (en) Enzyme inhibitor
CA969944A (en) Hydrazonium salt, production of the same and composition thereof
CA841578A (en) Production of micro-organisms
CA842201A (en) Production of micro-organisms
CA843308A (en) Tractants and method of use
IL36707A0 (en) Enzyme product and process
CA857894A (en) DERIVATIVES OF .alpha.-PIPERAZINOPHENYL-ACETONITRILE AND PROCESS FOR MANUFACTURE OF SAME
CA840412A (en) Cultivation of micro-organisms
CA856222A (en) Cultivation of micro-organisms
CA857852A (en) Cultivation of micro-organisms
CA929943A (en) Substituted aminodihalopyridines and method of use
CA843953A (en) Heterocyclic derivatives of triphenylethylenes, triphenylethanes and triphenylethanols